Spots Global Cancer Trial Database for follicular lymphoma grade 2
Every month we try and update this database with for follicular lymphoma grade 2 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma | NCT03919175 | Lymphoma Follicular Lymp... Follicular Lymp... Follicular Lymp... Follicular Lymp... Marginal Zone L... Marginal Zone B... | Umbralisib Rituximab | 18 Years - | Massachusetts General Hospital |